European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology
Article first published online: 18 JUL 2007
Volume 18, Issue 4, pages 213–219, August 2007
How to Cite
Herbert, A., Bergeron, C., Wiener, H., Schenck, U., Klinkhamer, P., Bulten, J. and Arbyn, M. (2007), European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology. Cytopathology, 18: 213–219. doi: 10.1111/j.1365-2303.2007.00469.x
- Issue published online: 18 JUL 2007
- Article first published online: 18 JUL 2007
- Accepted for publication 20 April 2007
- 4European Commission. In: European Guidelines for Quality Assurance in Cervical Cancer Screening. ArbynM, AnttilaA, JordanJ, RoncoG, SchenckU, SegnanN, WienerH (eds). Luxembourg: Office of Official Publ EU; 2007 (in press).
- 5The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria and Explanatory Notes, 2nd edn. New York: Springer; 2004., .
- 6National Health Service Cervical Screening Programme. Achievable Standards, Benchmarks for Reporting, and Criteria for Evaluating Cervical Cytopathology. Second edition including revised performance indicators. NHSCSP publication 1. Sheffield: NHS Cancer Screening Programmes; 2000: pp. 1–36.
- 9Cytology of the Female Genital Tract. Geneva: World Health Organization; 1973., , .
- 13World Health Organization. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
- 15Borderline Nuclear Changes National Slide Exchange Study Group. Quality Assurance Reference Centre for the Trent NHSCSP. Do borderline nuclear changes in gynaecological cytology constitute a reliable reporting category? Cytopathology 2002;13:220–31.